{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:23:37Z","timestamp":1787739817024,"version":"build-2784847793"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014055","name":"U.S. Army Medical Research Acquisition Activity","doi-asserted-by":"publisher","award":["W81XWH1810805"],"award-info":[{"award-number":["W81XWH1810805"]}],"id":[{"id":"10.13039\/100014055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY032573"],"award-info":[{"award-number":["R01EY032573"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012643","name":"Ohio Lions Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2025.118943","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:34:41Z","timestamp":1768466081000},"page":"118943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["MIF inhibition attenuates proliferative vitreoretinopathy pathogenesis and protects the eye in preclinical model"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2647-0308","authenticated-orcid":false,"given":"Sumaya","family":"Hamadmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Heisler-Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Summitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf","family":"Shalash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-0936","authenticated-orcid":false,"given":"Julie","family":"Racine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Cebulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2025.118943_bib1","first-page":"1166","article-title":"Post-traumatic proliferative vitreoretinopathy","volume":"104","author":"Cardillo","year":"1997","journal-title":"Epidemiol. Profile onset risk Factors Vis. Outcome Ophthalmol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118943_bib2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ajo.2004.02.008","article-title":"Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery","volume":"137","author":"Tseng","year":"2004","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118943_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41433-019-0724-4","article-title":"A brief review of the histopathology of proliferative vitreoretinopathy (PVR)","volume":"34","author":"Mudhar","year":"2020","journal-title":"Eye (Lond. )"},{"key":"10.1016\/j.biopha.2025.118943_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","article-title":"Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences","volume":"51","author":"Pastor","year":"2016","journal-title":"Prog. Retin Eye Res"},{"issue":"110","key":"10.1016\/j.biopha.2025.118943_bib5","first-page":"207","article-title":"Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy","volume":"20","author":"Yang","year":"2015","journal-title":"Discov. Med"},{"issue":"6","key":"10.1016\/j.biopha.2025.118943_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.preteyeres.2009.07.001","article-title":"Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects","volume":"28","author":"Bringmann","year":"2009","journal-title":"Prog. Retin Eye Res"},{"issue":"6","key":"10.1016\/j.biopha.2025.118943_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.31083\/j.fbl2706169","article-title":"Harnessing the Neuroprotective Behaviors of Muller Glia for Retinal Repair","volume":"27","author":"Pena","year":"2022","journal-title":"Front Biosci. (Landmark Ed."},{"key":"10.1016\/j.biopha.2025.118943_bib8","article-title":"The mechanics of the retina: Muller glia role on retinal extracellular matrix and modelling","volume":"11","author":"Prieto-Lopez","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118943_bib9","article-title":"MIF Inhibitor ISO-1 Protects Photoreceptors and Reduces Gliosis in Experimental Retinal Detachment","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118943_bib10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.fmre.2023.05.008","article-title":"Macrophage migration inhibitory factor (MIF) in CNS diseases: Functional regulation and potential therapeutic indication","volume":"4","author":"Zhang","year":"2024","journal-title":"Fundam. Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118943_bib11","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1167\/iovs.09-5057","article-title":"Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment","volume":"51","author":"Ricker","year":"2010","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118943_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9394(99)00368-2","article-title":"Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy","volume":"128","author":"Mitamura","year":"1999","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118943_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/med.21385","article-title":"Targeting MIF in cancer: Therapeutic strategies, current developments, and future opportunities","volume":"36","author":"O'Reilly","year":"2016","journal-title":"Med Res Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118943_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction","volume":"56","author":"David","year":"1966","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2025.118943_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1523-1755.2004.00394.x","article-title":"Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney","volume":"65","author":"Sasaki","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.biopha.2025.118943_bib16","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00521.2019","article-title":"The role of MIF in chronic lung diseases: looking beyond inflammation","volume":"318","author":"Florez-Sampedro","year":"2020","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118943_bib17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/glia.24657","article-title":"Ibudilast Protects Retinal Bipolar Cells From Excitotoxic Retinal Damage and Activates the mTOR Pathway","volume":"73","author":"Hamadmad","year":"2025","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2025.118943_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.05.007","article-title":"MIF promoter polymorphisms are associated with epiretinal membrane but not retinal detachment with PVR in an american population","volume":"185","author":"Cebulla","year":"2019","journal-title":"Exp. Eye Res"},{"issue":"9","key":"10.1016\/j.biopha.2025.118943_bib19","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1177\/1352458520964409","article-title":"Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis","volume":"27","author":"Bermel","year":"2021","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.biopha.2025.118943_bib20","first-page":"2760","article-title":"Pleiotropic role of macrophage migration inhibitory factor in cancer","volume":"9","author":"Guda","year":"2019","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118943_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116112","article-title":"Neuroprotective effects of ibudilast against tacrolimus induced neurotoxicity","volume":"449","author":"Zhang","year":"2022","journal-title":"Toxicol. Appl. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118943_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/nmt-2021-0042","article-title":"MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb\/III study: COMBAT-ALS study design","volume":"11","author":"Oskarsson","year":"2021","journal-title":"Neurodegener. Dis. Manag"},{"key":"10.1016\/j.biopha.2025.118943_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107811","article-title":"Significant upregulation of small heat shock protein alphaA-crystallin in retinal detachment","volume":"189","author":"Hamadmad","year":"2019","journal-title":"Exp. Eye Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.118943_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0161-6420(83)34588-7","article-title":"The classification of retinal detachment with proliferative vitreoretinopathy","volume":"90","year":"1983","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.biopha.2025.118943_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3109\/00498250903254340","article-title":"Cross-species comparisons of the pharmacokinetics of ibudilast","volume":"39","author":"Sanftner","year":"2009","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.biopha.2025.118943_bib26","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.ajpath.2013.01.052","article-title":"Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease","volume":"182","author":"Pennock","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118943_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1189\/jlb.3A0614-280R","article-title":"Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis","volume":"97","author":"Barnes","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118943_bib28","doi-asserted-by":"crossref","first-page":"L6","DOI":"10.1152\/ajplung.00288.2020","article-title":"Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats","volume":"321","author":"Luo","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1-3","key":"10.1016\/j.biopha.2025.118943_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2006.02.053","article-title":"The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family","volume":"538","author":"Gibson","year":"2006","journal-title":"Eur. J. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2025.118943_bib30","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1158\/1541-7786.MCR-14-0255-T","article-title":"MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma","volume":"12","author":"Nagarajan","year":"2014","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118943_bib31","article-title":"MIF inhibitors and their uses","author":"Gaweco","year":"2015","journal-title":"US Pat. Appl. US20150065480 A1"},{"issue":"5","key":"10.1016\/j.biopha.2025.118943_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.survophthal.2023.05.007","article-title":"In vitro laboratory models of proliferative vitreoretinopathy","volume":"68","author":"Gao","year":"2023","journal-title":"Surv. Ophthalmol."},{"issue":"13","key":"10.1016\/j.biopha.2025.118943_bib33","first-page":"4324","article-title":"Promotion of adhesion and migration of RPE cells to provisional extracellular matrices by TNF-alpha","volume":"41","author":"Jin","year":"2000","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2025.118943_bib34","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10136","article-title":"Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy","volume":"8","author":"Zou","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.biopha.2025.118943_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fcell.2020.00501","article-title":"Role of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelium Dysfunction","volume":"8","author":"Zhou","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118943_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000438972","article-title":"Retinal Detachment and Proliferative Vitreoretinopathy","volume":"55","author":"Kwon","year":"2016","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118943_bib37","first-page":"2511","article-title":"Expression profiles of nestin and synemin in reactive astrocytes and Muller cells following retinal injury: a comparison with glial fibrillar acidic protein and vimentin","volume":"16","author":"Luna","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2025.118943_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0074-7696(03)30005-1","article-title":"Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression","volume":"230","author":"Lewis","year":"2003","journal-title":"Int Rev. Cytol."},{"key":"10.1016\/j.biopha.2025.118943_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.preteyeres.2017.06.004","article-title":"The chick eye in vision research: An excellent model for the study of ocular disease","volume":"61","author":"Wisely","year":"2017","journal-title":"Prog. Retin Eye Res"},{"issue":"9","key":"10.1016\/j.biopha.2025.118943_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044257","article-title":"A chick model of retinal detachment: cone rich and novel","volume":"7","author":"Cebulla","year":"2012","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.biopha.2025.118943_bib41","doi-asserted-by":"crossref","first-page":"11313","DOI":"10.1073\/pnas.1002716107","article-title":"Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast","volume":"107","author":"Cho","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2025.118943_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0002-9394(14)77369-6","article-title":"A comparison of different cellular inocula in an experimental model of massive periretinal proliferation","volume":"93","author":"Fastenberg","year":"1982","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118943_bib43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00417-023-06264-1","article-title":"Proliferative vitreoretinopathy: an update on the current and emerging treatment options","volume":"262","author":"Ferro Desideri","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118943_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4081\/842","article-title":"Immunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetamide","volume":"47","author":"Hori","year":"2003","journal-title":"Eur. J. Histochem"},{"issue":"12","key":"10.1016\/j.biopha.2025.118943_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124105","article-title":"Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis","volume":"19","author":"Gunther","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118943_bib46","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.18632\/aging.202505","article-title":"Macrophage migration inhibitory factor activates the inflammatory response in joint capsule fibroblasts following post-traumatic joint contracture","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.biopha.2025.118943_bib47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nat. Rev. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2025.118943_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12348-023-00361-2","article-title":"Targeting macrophage migration inhibitory factor (MIF): a promising therapy for inflammatory ocular diseases","volume":"13","author":"Vazquez","year":"2023","journal-title":"J. Ophthalmic Inflamm. Infect."},{"issue":"1","key":"10.1016\/j.biopha.2025.118943_bib49","first-page":"830","article-title":"Effect of macrophage migration inhibitory factor on inflammatory cytokines and fibrogenic gene expression in human RPE cells","volume":"20","author":"Qin","year":"2019","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2025.118943_bib50","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3389\/fimmu.2019.02752","article-title":"The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy","volume":"10","author":"Abu El-Asrar","year":"2019","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118943_bib51","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00592-016-0956-8","article-title":"Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model","volume":"54","author":"Wang","year":"2017","journal-title":"Acta Diabetol."},{"issue":"37","key":"10.1016\/j.biopha.2025.118943_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2424487122","article-title":"Single-cell transcriptome combined with genetic tracing reveals a roadmap of fibrosis formation during proliferative vitreoretinopathy","volume":"122","author":"Liao","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2025.118943_bib53","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1038\/s41467-024-51624-y","article-title":"Multi-omics profiling of retinal pigment epithelium reveals enhancer-driven activation of RANK-NFATc1 signaling in traumatic proliferative vitreoretinopathy","volume":"15","author":"Liao","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2025.118943_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/02770909209048938","article-title":"Effect of ibudilast: a novel antiasthmatic agent, on airway hypersensitivity in bronchial asthma","volume":"29","author":"Kawasaki","year":"1992","journal-title":"J. Asthma"},{"issue":"17","key":"10.1016\/j.biopha.2025.118943_bib55","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1517\/14656560903426189","article-title":"Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease","volume":"10","author":"Rolan","year":"2009","journal-title":"Expert Opin. Pharm."},{"issue":"23","key":"10.1016\/j.biopha.2025.118943_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238448","article-title":"Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence","volume":"27","author":"Angelopoulou","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118943_bib57","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118943_bib58","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1097\/IAE.0000000000004181","article-title":"Intravitreal Methotrexate Injection for the Treatment and Prevention of Proliferative Vitreoretinopathy","volume":"44","author":"Hughes","year":"2024","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.biopha.2025.118943_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3928\/23258160-20220920-04","article-title":"Intravitreal Methotrexate for the Prevention and Treatment of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment: A Systematic Review","volume":"53","author":"Balas","year":"2022","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:08:56Z","timestamp":1781842136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":59,"alternative-id":["S0753332225011370"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118943","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MIF inhibition attenuates proliferative vitreoretinopathy pathogenesis and protects the eye in preclinical model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118943"}}